Cost Burden of MS in the U.S.
Dr. Bruce Bebo discusses the economic burden of multiple sclerosis in the U.S. Show references: https://n.neurology.org/content/early/2022/04/13/WNL.0000000000200150 https://www.nationalmssociety.or...
4 Touko 20221min
Genetics and Neuroinflammation, Considerations for the Clinician - Part 2
Dr. Shuvro Roy discusses TNF-alpha Antagonism.
3 Touko 20222min
Genetics and Neuroinflammation, Considerations for the Clinician - Part 1
Dr. Shuvro Roy discusses CTLA4 Haploinsufficiency.
2 Touko 20223min
Combined Prophylactic Treatment of Chronic Migraine
Audrey Blazek, a 4th-year medical student at Rush Medical College, discusses her abstract, "Combined Prophylactic Treatment of Chronic Migraine with OnabotulinumtoxinA and Anti-CGRP Monoclonal Antibod...
29 Huhti 20222min
Sudden Death and Cardiac Arrhythmia with Lamotrigine
Dr. Mark Keezer discusses the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy. Show references:https://n.neurology.org/content/early/2022/03/08/WNL.00...
28 Huhti 20222min
Cognitive Decline in Patients with Parkinson's disease
Dr. Michael Fox discusses whether connectivity between sites of deep brain stimulation (DBS) and other brain regions is associated with DBS-induced cognitive decline in patients with Parkinson's disea...
27 Huhti 20221min
Evaluation of First Seizure and Newly Diagnosed Epilepsy - Part 2
In part 2 of a 2 part series, Elaine Wirrell, MD, FRCP(C), FAAN, discusses her article, "Evaluation of First Seizure and Newly Diagnosed Epilepsy" from the April Continuum Epilepsy issue. This article...
26 Huhti 20223min
Evaluation of First Seizure and Newly Diagnosed Epilepsy - Part 1
In part 1 of a 2 part series, Elaine Wirrell, MD, FRCP(C), FAAN, discusses her article, "Evaluation of First Seizure and Newly Diagnosed Epilepsy" from the April Continuum Epilepsy issue. This article...
25 Huhti 20222min
